FDA.reportPublic FDA data

Trileptal 300 MG in 5 mL Oral Suspension

RxCUI
351992
RxNorm name
Trileptal 300 MG in 5 mL Oral Suspension
Display name
Trileptal 300 MG in 5 mL Oral Suspension
Full name
Trileptal 300 MG in 5 mL Oral Suspension
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:38:57

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
4c5c86c8-ab7f-4fcf-bc1b-5a0b1fd0691bTrileptal 300 MG in 5 mL Oral Suspension [PSN] · oxcarbazepine 60 MG/ML Oral Suspension [Trileptal] [SBD] · Trileptal 300 MG per 5 ML Oral Suspension [SY] · Trileptal 60 MG/ML Oral Suspension [SY]439These highlights do not include all the information needed to use TRILEPTAL safely and effectively. See full prescribing information for TRILEPTAL. TRILEPTAL ® (oxcarbazepine) film-coated tablets, for oral use TRILEPTAL ® (oxcarbazepine) oral suspension Initial U.S. Approval: 200020251216